SAUHY
Straumann Holding AG [SAUHY] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
SAUHY Stock Summary
Top 10 Correlated ETFs
SAUHY
Top 10 Correlated Stocks
SAUHY
In the News
Straumann Holding AG (SAUHF) Q4 2022 Earnings Call Transcript
Straumann Holding AG (OTCPK:SAUHF) Q4 2022 Earnings Conference Call February 21, 2023 4:30 AM ET Company Participants Guillaume Daniellot - CEO Marcel Kellerhals - Head IR & Corporate Finance Conference Call Participants Daniel Buchta - ZKB Chris Gretler - Credit Suisse Maja Pataki - Kepler Daniel Jelovcan - Stifel James Vane-Tempest - Jefferies Falko Friedrichs - Deutsche Bank Veronika Dubajova - Citigroup Graham Doyle - UBS Oliver Metzger - ODDO Shubhangi Gupta - HSBC Operator Ladies and gentlemen, welcome to the Straumann Group Full Year 2022 Results Conference Call and Live Webcast. I'm Alice, the Chorus Call operator.
Straumann: A Swiss Leader Trading At A Favorable Valuation
Straumann is a Swiss company that is a leader in dental replacement and orthodontic solutions. Straumann's products include dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. Total stock returns are high, averaging 27% per year over the past decade.
Straumann Holding AG (SAUHF) Q3 2022 Earnings Call Transcript
Straumann Holding AG (OTCPK:SAUHF) Q3 2022 Results Conference Call November 2, 2022 5:30 AM ET Company Participants Guillaume Daniellot - CEO Peter Hackel - CFO Conference Call Participants Christoph Gretler - Credit Suisse Julien Dormois - BNP Paribas Daniel Jelovcan - Stifel Maja Pataki - Kepler Daniel Buchta - ZKB James Vane-Tempest - Jefferies Falko Friedrichs - Deutsche Bank Oliver Metzger - ODDO Veronika Dubajova - Citi Guillaume Daniellot Good morning everyone, and thank you for joining this conference call on Straumann Group's third quarter results. Please take notes of the disclaimer in our press release and on Slide 2.
Straumann Holding AG (SAUHF) CEO Guillaume Daniellot on Q2 2022 Results - Earnings Call Transcript
Straumann Holding AG (OTCPK:SAUHF) Q2 2022 Results Conference Call August 16, 2022 4:30 AM ET Company Participants Guillaume Daniellot - Chief Executive Officer Peter Hackel - Chief Financial Officer Conference Call Participants Patrick Wood - Bank of America Chris Gretler - Crédit Suisse Daniel Buchta - ZKB Julien Dormois - BNP Veronika Dubajova - Citi Oliver Metzger - ODDO Maja Pataki - Kepler Cheuvreux Graham Doyle - UBS Grace Lee - Jefferies Falko Friedrichs - Deutsche Bank Holger Frisch - Zürcher Kantonalbank Guillaume Daniellot Good morning, everyone. Thank you for joining this conference call about Straumann Group's First Half Year Report for 2022.
Straumann Holding AG (SAUHF) CEO Guillaume Daniellot on Q4 2021 Results - Earnings Call Transcript
Straumann Holding AG (SAUHF) CEO Guillaume Daniellot on Q4 2021 Results - Earnings Call Transcript
SAUHY Financial details
SAUHY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.17 | 0.2 | 0.18 | 0.25 | 1.46 | |
| Net income per share | 0.03 | 0.04 | 0.01 | 0.05 | 0.27 | |
| Operating cash flow per share | 0.04 | 0.05 | 0.05 | 0.07 | 0.26 | |
| Free cash flow per share | 0.02 | 0.03 | 0.04 | 0.06 | 0.14 | |
| Cash per share | 0.04 | 0.03 | 0.08 | 0.11 | 0.44 | |
| Book value per share | 0.15 | 0.17 | 0.15 | 0.19 | 1.16 | |
| Tangible book value per share | 0.07 | 0.08 | 0.07 | 0.11 | 0.68 | |
| Share holders equity per share | 0.15 | 0.17 | 0.15 | 0.19 | 1.16 | |
| Interest debt per share | 0.03 | 0.06 | 0.09 | 0.09 | 0.45 | |
| Market cap | 24.21B | 37.85B | 42.02B | 78.09B | 16.65B | |
| Enterprise value | 24.13B | 38.05B | 42.11B | 77.92B | 16.66B | |
| P/E ratio | 88.76 | 123.51 | 460.36 | 197.16 | 38.3 | |
| Price to sales ratio | 17.76 | 23.71 | 29.47 | 38.62 | 7.18 | |
| POCF ratio | 87.37 | 100.01 | 111.59 | 139.37 | 40.12 | |
| PFCF ratio | 144.66 | 165.57 | 142.68 | 177.75 | 75.8 | |
| P/B Ratio | 20.16 | 27.76 | 34.88 | 52.22 | 8.99 | |
| PTB ratio | 20.16 | 27.76 | 34.88 | 52.22 | 8.99 | |
| EV to sales | 17.7 | 23.84 | 29.54 | 38.54 | 7.18 | |
| Enterprise value over EBITDA | 63.09 | 80.09 | 184.69 | 131.08 | 24.56 | |
| EV to operating cash flow | 87.09 | 100.53 | 111.83 | 139.06 | 40.13 | |
| EV to free cash flow | 144.2 | 166.42 | 142.99 | 177.35 | 75.82 | |
| Earnings yield | 0.01 | 0.01 | 0 | 0.01 | 0.03 | |
| Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Debt to equity | 0.55 | 0.75 | 1.11 | 0.98 | 0.82 | |
| Debt to assets | 0.35 | 0.43 | 0.53 | 0.49 | 0.45 | |
| Net debt to EBITDA | -0.2 | 0.41 | 0.39 | -0.29 | 0.01 | |
| Current ratio | 2.81 | 1.52 | 3.04 | 2.72 | 1.64 | |
| Interest coverage | 39.26 | 21.97 | 10.02 | 31.85 | 31.14 | |
| Income quality | 1.02 | 1.23 | 4.13 | 1.41 | 0.95 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0.01 | |
| Payout ratio | 0.28 | 0.27 | 1 | 0.23 | 0.25 | |
| Sales general and administrative to revenue | 0.29 | 0.31 | 0.41 | 0.31 | 0.34 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.35 | 0.31 | 0.26 | 0.22 | 0.23 | |
| Capex to operating cash flow | -0.4 | -0.4 | -0.22 | -0.22 | -0.47 | |
| Capex to revenue | -0.08 | -0.09 | -0.06 | -0.06 | -0.08 | |
| Capex to depreciation | -2.1 | -1.6 | -0.83 | -1.17 | -1.2 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
| Graham number | 0.34 | 0.39 | 0.2 | 0.46 | 2.67 | |
| ROIC | 0.24 | 0.19 | 0.11 | 0.46 | 0.28 | |
| Return on tangible assets | 0.23 | 0.19 | 0.05 | 0.17 | 0.17 | |
| Graham Net | -0.04 | -0.08 | -0.08 | -0.06 | -0.42 | |
| Working capital | 493.05M | 302.68M | 772.83M | 966.04M | 621.11M | |
| Tangible asset value | 551.88M | 624.38M | 559.66M | 861.56M | 1.08B | |
| Net current asset value | 104.78M | -141.09M | -186.42M | 61.08M | 73.63M | |
| Invested capital | 0.17 | 0.33 | 0.6 | 0.47 | 0.38 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 98.9M | 122.13M | 143.06M | 177.71M | 253.41M | |
| Average inventory | 167.1M | 208.3M | 225.56M | 232.9M | 285.2M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 107.93 | 131.38 | 132.39 | 160.4 | 190.25 | |
| Days of inventory on hand | 192.99 | 216.33 | 199.58 | 188.78 | 207.1 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 3.38 | 2.78 | 2.76 | 2.28 | 1.92 | |
| Inventory turnover | 1.89 | 1.69 | 1.83 | 1.93 | 1.76 | |
| ROE | 0.23 | 0.22 | 0.08 | 0.26 | 0.23 | |
| Capex per share | -0.01 | -0.02 | -0.01 | -0.02 | -0.12 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
| Metric | History | 2020-12-31 | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value | 89.85M | -725.38M | -173.85M | -734.8M | 5.49M | |
| P/E ratio | 0 | 0 | 0 | 0 | 0 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
| PTB ratio | 0 | 0 | 0 | 0 | 0 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 1.11 | 1.06 | 0.98 | 0.82 | 0.82 | |
| Debt to assets | 0.53 | 0.51 | 0.49 | 0.45 | 0.45 | |
| Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
| Current ratio | 3.04 | 2.95 | 2.72 | 2.84 | 1.64 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.26 | 0 | 0.22 | 0.22 | 0.23 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | 0 | 0 | 0 | 0 | 0 | |
| Working capital | 772.83M | 900.78M | 966.04M | 1B | 621.11M | |
| Tangible asset value | 559.66M | 1.37B | 861.56M | 1.05B | 1.08B | |
| Net current asset value | -186.42M | -85.21M | 61.08M | 108.25M | 73.63M | |
| Invested capital | 0.6 | 0 | 0.47 | 0 | 0.38 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 180.71M | 261.31M | 295.36M | 330.74M | 372.38M | |
| Average inventory | 220.16M | 228.04M | 244.37M | 272.8M | 308.77M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0 | 0 | 0 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
SAUHY Frequently Asked Questions
What is Straumann Holding AG stock symbol ?
Straumann Holding AG is a CH stock and trading under the symbol SAUHY
What is Straumann Holding AG stock quote today ?
Straumann Holding AG stock price is $14.8684 today.
Is Straumann Holding AG stock public?
Yes, Straumann Holding AG is a publicly traded company.
Company Profile
- Volume Average 84.03K
- Market Capitalization 23.69B
- Employee 9.88K
- CEO Mr. Guillaume Daniellot
- Headquarters Basel,CH
- IPO Date 2014-12-19
-
Website
https://www.straumann.com 
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics. It provides ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products. In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing. Further, it offers systems Clear Correct aligners; and training and education services to its customers. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
